Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder

Lucina Q Uddin, D. R. Dajani, W. Voorhies, H. Bednarz, R. K. Kana

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Children with neurodevelopmental disorders benefit most from early interventions and treatments. The development and validation of brain-based biomarkers to aid in objective diagnosis can facilitate this important clinical aim. The objective of this review is to provide an overview of current progress in the use of neuroimaging to identify brain-based biomarkers for autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), two prevalent neurodevelopmental disorders. We summarize empirical work that has laid the foundation for using neuroimaging to objectively quantify brain structure and function in ways that are beginning to be used in biomarker development, noting limitations of the data currently available. The most successful machine learning methods that have been developed and applied to date are discussed. Overall, there is increasing evidence that specific features (for example, functional connectivity, gray matter volume) of brain regions comprising the salience and default mode networks can be used to discriminate ASD from typical development. Brain regions contributing to successful discrimination of ADHD from typical development appear to be more widespread, however there is initial evidence that features derived from frontal and cerebellar regions are most informative for classification. The identification of brain-based biomarkers for ASD and ADHD could potentially assist in objective diagnosis, monitoring of treatment response and prediction of outcomes for children with these neurodevelopmental disorders. At present, however, the field has yet to identify reliable and reproducible biomarkers for these disorders, and must address issues related to clinical heterogeneity, methodological standardization and cross-site validation before further progress can be achieved.

Original languageEnglish (US)
Pages (from-to)e1218
JournalTranslational Psychiatry
Volume7
Issue number8
DOIs
StatePublished - Aug 22 2017
Externally publishedYes

Fingerprint

Attention Deficit Disorder with Hyperactivity
Autistic Disorder
Biomarkers
Brain
Neuroimaging
Therapeutics
Autism Spectrum Disorder
Neurodevelopmental Disorders

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Biological Psychiatry

Cite this

Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder. / Uddin, Lucina Q; Dajani, D. R.; Voorhies, W.; Bednarz, H.; Kana, R. K.

In: Translational Psychiatry, Vol. 7, No. 8, 22.08.2017, p. e1218.

Research output: Contribution to journalReview article

@article{166c1da28dd44f07af530debff8eebc4,
title = "Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder",
abstract = "Children with neurodevelopmental disorders benefit most from early interventions and treatments. The development and validation of brain-based biomarkers to aid in objective diagnosis can facilitate this important clinical aim. The objective of this review is to provide an overview of current progress in the use of neuroimaging to identify brain-based biomarkers for autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), two prevalent neurodevelopmental disorders. We summarize empirical work that has laid the foundation for using neuroimaging to objectively quantify brain structure and function in ways that are beginning to be used in biomarker development, noting limitations of the data currently available. The most successful machine learning methods that have been developed and applied to date are discussed. Overall, there is increasing evidence that specific features (for example, functional connectivity, gray matter volume) of brain regions comprising the salience and default mode networks can be used to discriminate ASD from typical development. Brain regions contributing to successful discrimination of ADHD from typical development appear to be more widespread, however there is initial evidence that features derived from frontal and cerebellar regions are most informative for classification. The identification of brain-based biomarkers for ASD and ADHD could potentially assist in objective diagnosis, monitoring of treatment response and prediction of outcomes for children with these neurodevelopmental disorders. At present, however, the field has yet to identify reliable and reproducible biomarkers for these disorders, and must address issues related to clinical heterogeneity, methodological standardization and cross-site validation before further progress can be achieved.",
author = "Uddin, {Lucina Q} and Dajani, {D. R.} and W. Voorhies and H. Bednarz and Kana, {R. K.}",
year = "2017",
month = "8",
day = "22",
doi = "10.1038/tp.2017.164",
language = "English (US)",
volume = "7",
pages = "e1218",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder

AU - Uddin, Lucina Q

AU - Dajani, D. R.

AU - Voorhies, W.

AU - Bednarz, H.

AU - Kana, R. K.

PY - 2017/8/22

Y1 - 2017/8/22

N2 - Children with neurodevelopmental disorders benefit most from early interventions and treatments. The development and validation of brain-based biomarkers to aid in objective diagnosis can facilitate this important clinical aim. The objective of this review is to provide an overview of current progress in the use of neuroimaging to identify brain-based biomarkers for autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), two prevalent neurodevelopmental disorders. We summarize empirical work that has laid the foundation for using neuroimaging to objectively quantify brain structure and function in ways that are beginning to be used in biomarker development, noting limitations of the data currently available. The most successful machine learning methods that have been developed and applied to date are discussed. Overall, there is increasing evidence that specific features (for example, functional connectivity, gray matter volume) of brain regions comprising the salience and default mode networks can be used to discriminate ASD from typical development. Brain regions contributing to successful discrimination of ADHD from typical development appear to be more widespread, however there is initial evidence that features derived from frontal and cerebellar regions are most informative for classification. The identification of brain-based biomarkers for ASD and ADHD could potentially assist in objective diagnosis, monitoring of treatment response and prediction of outcomes for children with these neurodevelopmental disorders. At present, however, the field has yet to identify reliable and reproducible biomarkers for these disorders, and must address issues related to clinical heterogeneity, methodological standardization and cross-site validation before further progress can be achieved.

AB - Children with neurodevelopmental disorders benefit most from early interventions and treatments. The development and validation of brain-based biomarkers to aid in objective diagnosis can facilitate this important clinical aim. The objective of this review is to provide an overview of current progress in the use of neuroimaging to identify brain-based biomarkers for autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), two prevalent neurodevelopmental disorders. We summarize empirical work that has laid the foundation for using neuroimaging to objectively quantify brain structure and function in ways that are beginning to be used in biomarker development, noting limitations of the data currently available. The most successful machine learning methods that have been developed and applied to date are discussed. Overall, there is increasing evidence that specific features (for example, functional connectivity, gray matter volume) of brain regions comprising the salience and default mode networks can be used to discriminate ASD from typical development. Brain regions contributing to successful discrimination of ADHD from typical development appear to be more widespread, however there is initial evidence that features derived from frontal and cerebellar regions are most informative for classification. The identification of brain-based biomarkers for ASD and ADHD could potentially assist in objective diagnosis, monitoring of treatment response and prediction of outcomes for children with these neurodevelopmental disorders. At present, however, the field has yet to identify reliable and reproducible biomarkers for these disorders, and must address issues related to clinical heterogeneity, methodological standardization and cross-site validation before further progress can be achieved.

UR - http://www.scopus.com/inward/record.url?scp=85044957397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044957397&partnerID=8YFLogxK

U2 - 10.1038/tp.2017.164

DO - 10.1038/tp.2017.164

M3 - Review article

C2 - 28892073

AN - SCOPUS:85044957397

VL - 7

SP - e1218

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

IS - 8

ER -